Works by Kuruvilla, John

Results: 99
    1
    2
    3

    Phase Ib study of avadomide (CC‐122) in combination with rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma and follicular lymphoma.

    Published in:
    EJHaem, 2022, v. 3, n. 2, p. 394, doi. 10.1002/jha2.394
    By:
    • Nastoupil, Loretta J.;
    • Kuruvilla, John;
    • Chavez, Julio C.;
    • Bijou, Fontanet;
    • Witzig, Thomas E.;
    • Santoro, Armando;
    • Flinn, Ian W.;
    • Boccomini, Carola;
    • Kenkre, Vaishalee P.;
    • Corradini, Paolo;
    • Isufi, Iris;
    • Andorsky, David J.;
    • Klein, Leonard M.;
    • Greenwald, Daniel R.;
    • Sangha, Randeep;
    • Shen, Frank;
    • Hagner, Patrick;
    • Li, Yan;
    • Dobmeyer, Juergen;
    • Gong, Nian
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Resources-Stratified Guidelines for Classical Hodgkin Lymphoma.

    Published in:
    International Journal of Environmental Research & Public Health, 2020, v. 17, n. 5, p. 1783, doi. 10.3390/ijerph17051783
    By:
    • Relecom, Allan;
    • Federico, Massimo;
    • Connors, Joseph M.;
    • Coiffier, Bertrand;
    • Biasoli, Irene;
    • Moccia, Alden;
    • Salles, Gilles;
    • McKee, Thomas;
    • Miralbell, Raymond;
    • Borchmann, Peter;
    • Kuruvilla, John;
    • Johnson, Peter;
    • Cavalli, Franco;
    • Delavy, Martine;
    • Dietrich, Pierre-Yves;
    • Flahault, Antoine
    Publication type:
    Article
    10

    Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 12, p. 1538, doi. 10.1002/ajh.26726
    By:
    • Lackraj, Tracy;
    • Ben Barouch, Sharon;
    • Medeiros, Jessie J. F.;
    • Pedersen, Stephanie;
    • Danesh, Arnavaz;
    • Bakhtiari, Mehran;
    • Hong, Michael;
    • Tong, Kit;
    • Joynt, Jesse;
    • Arruda, Andrea;
    • Minden, Mark D.;
    • Kuruvilla, John;
    • Bhella, Sita;
    • Kukreti, Vishal;
    • Crump, Michael;
    • Prica, Anca;
    • Chen, Christine;
    • Deng, Yangqing;
    • Xu, Wei;
    • Pugh, Trevor J.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    P1078: MOSUNETUZUMAB DEMONSTRATES DURABLE RESPONSES IN PATIENTS WITH RELAPSED AND/OR REFRACTORY FOLLICULAR LYMPHOMA WHO HAVE RECEIVED ≥2 PRIOR THERAPIES: UPDATED ANALYSIS OF A PIVOTAL PHASE II STUDY.

    Published in:
    2023
    By:
    • Sehn, Laurie H.;
    • Bartlett, Nancy L.;
    • Matasar, Matthew;
    • Schuster, Stephen J.;
    • Assouline, Sarit;
    • Kuruvilla, John;
    • Shadman, Mazyar;
    • Cheah, Chan;
    • Fay, Keith;
    • Ku, Matthew;
    • Nastoupil, Loretta J.;
    • Wei, Michael;
    • Yin, Shen;
    • To, Iris;
    • Hu, Nan;
    • Min, Juliana;
    • Penuel, Elicia;
    • Belousov, Anton;
    • Coimbra, Alexandre;
    • Jemaa, Skander
    Publication type:
    Abstract
    22

    P1065: UPDATED RESULTS FROM AN OPEN-LABEL PHASE 1/2 STUDY OF FAVEZELIMAB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANTI–PD-1–NAIVE RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA.

    Published in:
    2023
    By:
    • Johnson, Nathalie;
    • Lavie, David;
    • Borchmann, Peter;
    • Gregory, Gareth;
    • Herrera, Alex F.;
    • Minuk, Leonard;
    • Vucinic, Vladan;
    • Armand, Philippe;
    • Avigdor, Abraham;
    • Gasiorowski, Robin;
    • Herishanu, Yair;
    • Keane, Colm;
    • Kuruvilla, John;
    • Marceau West, Rachel;
    • Pillai, Pallavi;
    • Marinello, Patricia;
    • Timmerman, John
    Publication type:
    Abstract
    23

    P061: Safety and Dose‐Expansion Study of Combination Favezelimab (anti–LAG‐3) Plus Pembrolizumab in Anti–PD‐1–Naive Patients With Relapsed or Refractory Classical Hodgkin Lymphoma.

    Published in:
    HemaSphere, 2022, v. 6, p. 28, doi. 10.1097/01.HS9.0000890812.66186.e8
    By:
    • Borchmann, Peter;
    • Johnson, Nathalie A.;
    • Lavie, David;
    • Gregory, Gareth;
    • Herrera, Alex F.;
    • Minuk, Leonard;
    • Vucinic, Vladan;
    • Armand, Philippe;
    • Avigdor, Abraham;
    • Gasiorowski, Robin;
    • Herishanu, Yair;
    • Keane, Colm;
    • Kuruvilla, John;
    • Palcza, John;
    • Pillai, Pallavi;
    • Nahar, Akash;
    • Timmerman, John
    Publication type:
    Article
    24

    A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD‐FL).

    Published in:
    HemaSphere, 2022, v. 6, n. 7, p. e745, doi. 10.1097/HS9.0000000000000745
    By:
    • Salles, Gilles;
    • Schuster, Stephen J.;
    • Fischer, Luca;
    • Kuruvilla, John;
    • Patten, Piers E. M.;
    • von Tresckow, Bastian;
    • Smith, Sonali;
    • Jiménez‐Ubieto, Ana;
    • Davis, Keith L.;
    • Nagar, Saurabh;
    • Zhang, Jie;
    • Bollu, Vamsi;
    • Jousseaume, Etienne;
    • Ramos, Roberto;
    • Wang, Yucai;
    • Link, Brian K.
    Publication type:
    Article
    25
    26

    Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 1, p. 130, doi. 10.1080/10428194.2022.2136956
    By:
    • Kuruvilla, John;
    • Armand, Philippe;
    • Hamadani, Mehdi;
    • Kline, Justin;
    • Moskowitz, Craig H.;
    • Avigan, David;
    • Brody, Joshua D.;
    • Ribrag, Vincent;
    • Herrera, Alex F.;
    • Morschhauser, Franck;
    • Kanate, Abraham;
    • Zinzani, Pier Luigi;
    • Bitran, Jacob;
    • Ghesquieres, Herve;
    • Schuster, Stephen J.;
    • Farooqui, Mohammed;
    • Marinello, Patricia;
    • Bartlett, Nancy L.
    Publication type:
    Article
    27
    28
    29
    30

    Prolonged progression free survival in a subset of responders to the combination of brentuximab vedotin and bendamustine in heavily treated patients with relapsed or refractory Hodgkin lymphoma: updated results from an international multi-center phase I/II experience

    Published in:
    2020
    By:
    • Sawas, Ahmed;
    • Ma, Helen;
    • Kuruvilla, John;
    • Lue, Jennifer K.;
    • Deng, Changchun;
    • Marchi, Enrica;
    • Montanari, Francesca;
    • Cheng, Bin;
    • Savage, Kerry J.;
    • Villa, Diego;
    • Crump, Michael;
    • Connors, Joseph M.;
    • O'Connor, Owen A.
    Publication type:
    Letter
    31
    32
    33
    34

    A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 4, p. 912, doi. 10.1080/10428194.2018.1515937
    By:
    • Reiman, Tony;
    • Savage, Kerry J.;
    • Crump, Michael;
    • Cheung, Matthew C.;
    • MacDonald, David;
    • Buckstein, Rena;
    • Couban, Stephen;
    • Piliotis, Eugenia;
    • Imrie, Kevin;
    • Spaner, David;
    • Shivakumar, Sudeep;
    • Kuruvilla, John;
    • Villa, Diego;
    • Shepherd, Lois E.;
    • Skamene, Tanya;
    • Winch, Chad;
    • Chen, Bingshu E.;
    • Hay, Annette E.
    Publication type:
    Article
    35
    36
    37

    Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 10, p. 2319, doi. 10.1080/10428194.2017.1312379
    By:
    • Skamene, Tanya;
    • Crump, Michael;
    • Savage, Kerry J.;
    • Reiman, Tony;
    • Kuruvilla, John;
    • Good, David;
    • LeBrun, David;
    • Meyer, Ralph M.;
    • Sehn, Laurie H.;
    • Soulières, Denis;
    • Stakiw, Julie;
    • Laferriere, Nicole;
    • Luminari, Stefano;
    • Shepherd, Lois E.;
    • Djurfeldt, Marina;
    • Zhu, Liting;
    • Chen, Bingshu E.;
    • Hay, Annette E.
    Publication type:
    Article
    38

    The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 6, p. 1358, doi. 10.1080/10428194.2016.1239259
    By:
    • Seftel, Matthew D.;
    • Kuruvilla, John;
    • Kouroukis, Tom;
    • Banerji, Versha;
    • Fraser, Graeme;
    • Crump, Michael;
    • Kumar, Rajat;
    • Chalchal, Haji I.;
    • Salim, Muhammad;
    • Laister, Rob C.;
    • Crocker, Susan;
    • Gibson, Spencer B.;
    • Toguchi, Marcia;
    • Lyons, John F.;
    • Xu, Hao;
    • Powers, Jean;
    • Sederias, Joana;
    • Seymour, Lesley;
    • Hay, Annette E.
    Publication type:
    Article
    39

    Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 1, p. 64, doi. 10.1080/10428194.2016.1187274
    By:
    • Baetz, Tara;
    • Chen, Bingshu E.;
    • Couban, Stephen;
    • Tom Kouroukis, C.;
    • Buckstein, Rena;
    • Kuruvilla, John;
    • Howson-Jan, Kang;
    • Szwajcer, David;
    • Federico, Massimo;
    • Meyer, Ralph M.;
    • Djurfeldt, Marina S.;
    • Hay, Annette E.;
    • Shepherd, Lois;
    • Crump, Michael
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Phase IA/ II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non- Hodgkin or Hodgkin lymphoma.

    Published in:
    British Journal of Haematology, 2014, v. 164, n. 2, p. 258, doi. 10.1111/bjh.12630
    By:
    • Fanale, Michelle;
    • Assouline, Sarit;
    • Kuruvilla, John;
    • Solal‐Céligny, Philippe;
    • Heo, Dae S.;
    • Verhoef, Gregor;
    • Corradini, Paolo;
    • Abramson, Jeremy S.;
    • Offner, Fritz;
    • Engert, Andreas;
    • Dyer, Martin J. S.;
    • Carreon, Daniel;
    • Ewald, Brett;
    • Baeck, Johan;
    • Younes, Anas;
    • Freedman, Arnold S.
    Publication type:
    Article
    50